1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anti-inflammatory 1.2.3 Parasiticides 1.2.4 Others 1.3 Market by Application 1.3.1 Global Veterinary Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Veterinary Clinics 1.3.4 Drug Stores 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Veterinary Therapeutics Market Perspective (2016-2027) 2.2 Veterinary Therapeutics Growth Trends by Regions 2.2.1 Veterinary Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Veterinary Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Veterinary Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Veterinary Therapeutics Industry Dynamic 2.3.1 Veterinary Therapeutics Market Trends 2.3.2 Veterinary Therapeutics Market Drivers 2.3.3 Veterinary Therapeutics Market Challenges 2.3.4 Veterinary Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Veterinary Therapeutics Players by Revenue 3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Veterinary Therapeutics Revenue 3.4 Global Veterinary Therapeutics Market Concentration Ratio 3.4.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2020 3.5 Veterinary Therapeutics Key Players Head office and Area Served 3.6 Key Players Veterinary Therapeutics Product Solution and Service 3.7 Date of Enter into Veterinary Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Veterinary Therapeutics Breakdown Data by Type 4.1 Global Veterinary Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2022-2027) 5 Veterinary Therapeutics Breakdown Data by Application 5.1 Global Veterinary Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Veterinary Therapeutics Market Size (2016-2027) 6.2 North America Veterinary Therapeutics Market Size by Type 6.2.1 North America Veterinary Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Veterinary Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Veterinary Therapeutics Market Size by Type (2016-2027) 6.3 North America Veterinary Therapeutics Market Size by Application 6.3.1 North America Veterinary Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Veterinary Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Veterinary Therapeutics Market Size by Application (2016-2027) 6.4 North America Veterinary Therapeutics Market Size by Country 6.4.1 North America Veterinary Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Veterinary Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Veterinary Therapeutics Market Size (2016-2027) 7.2 Europe Veterinary Therapeutics Market Size by Type 7.2.1 Europe Veterinary Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Veterinary Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Veterinary Therapeutics Market Size by Type (2016-2027) 7.3 Europe Veterinary Therapeutics Market Size by Application 7.3.1 Europe Veterinary Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Veterinary Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Veterinary Therapeutics Market Size by Application (2016-2027) 7.4 Europe Veterinary Therapeutics Market Size by Country 7.4.1 Europe Veterinary Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Veterinary Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Veterinary Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Veterinary Therapeutics Market Size by Type 8.2.1 Asia-Pacific Veterinary Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Veterinary Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Veterinary Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Veterinary Therapeutics Market Size by Application 8.3.1 Asia-Pacific Veterinary Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Veterinary Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Veterinary Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Veterinary Therapeutics Market Size by Region 8.4.1 Asia-Pacific Veterinary Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Veterinary Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Veterinary Therapeutics Market Size (2016-2027) 9.2 Latin America Veterinary Therapeutics Market Size by Type 9.2.1 Latin America Veterinary Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Veterinary Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Veterinary Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Veterinary Therapeutics Market Size by Application 9.3.1 Latin America Veterinary Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Veterinary Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Veterinary Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Veterinary Therapeutics Market Size by Country 9.4.1 Latin America Veterinary Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Veterinary Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Veterinary Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Veterinary Therapeutics Market Size by Type 10.2.1 Middle East & Africa Veterinary Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Veterinary Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Veterinary Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Veterinary Therapeutics Market Size by Application 10.3.1 Middle East & Africa Veterinary Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Veterinary Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Veterinary Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Veterinary Therapeutics Market Size by Country 10.4.1 Middle East & Africa Veterinary Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Veterinary Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer AG 11.1.1 Bayer AG Company Details 11.1.2 Bayer AG Business Overview 11.1.3 Bayer AG Veterinary Therapeutics Introduction 11.1.4 Bayer AG Revenue in Veterinary Therapeutics Business (2016-2021) 11.1.5 Bayer AG Recent Development 11.2 Boehringer Ingelheim GmbH 11.2.1 Boehringer Ingelheim GmbH Company Details 11.2.2 Boehringer Ingelheim GmbH Business Overview 11.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Introduction 11.2.4 Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2016-2021) 11.2.5 Boehringer Ingelheim GmbH Recent Development 11.3 Ceva Sante Animale 11.3.1 Ceva Sante Animale Company Details 11.3.2 Ceva Sante Animale Business Overview 11.3.3 Ceva Sante Animale Veterinary Therapeutics Introduction 11.3.4 Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2016-2021) 11.3.5 Ceva Sante Animale Recent Development 11.4 Dechra Pharmaceuticals PLC 11.4.1 Dechra Pharmaceuticals PLC Company Details 11.4.2 Dechra Pharmaceuticals PLC Business Overview 11.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Introduction 11.4.4 Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2016-2021) 11.4.5 Dechra Pharmaceuticals PLC Recent Development 11.5 Eli Lilly and Company (Elanco Animal Health) 11.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details 11.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview 11.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Introduction 11.5.4 Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021) 11.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Development 11.6 Merck Animal Health 11.6.1 Merck Animal Health Company Details 11.6.2 Merck Animal Health Business Overview 11.6.3 Merck Animal Health Veterinary Therapeutics Introduction 11.6.4 Merck Animal Health Revenue in Veterinary Therapeutics Business (2016-2021) 11.6.5 Merck Animal Health Recent Development 11.7 Sanofi (Merial Animal Health) 11.7.1 Sanofi (Merial Animal Health) Company Details 11.7.2 Sanofi (Merial Animal Health) Business Overview 11.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Introduction 11.7.4 Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021) 11.7.5 Sanofi (Merial Animal Health) Recent Development 11.8 Virbac 11.8.1 Virbac Company Details 11.8.2 Virbac Business Overview 11.8.3 Virbac Veterinary Therapeutics Introduction 11.8.4 Virbac Revenue in Veterinary Therapeutics Business (2016-2021) 11.8.5 Virbac Recent Development 11.9 Vetoquinol S.A. 11.9.1 Vetoquinol S.A. Company Details 11.9.2 Vetoquinol S.A. Business Overview 11.9.3 Vetoquinol S.A. Veterinary Therapeutics Introduction 11.9.4 Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2016-2021) 11.9.5 Vetoquinol S.A. Recent Development 11.10 Zoetis, Inc. 11.10.1 Zoetis, Inc. Company Details 11.10.2 Zoetis, Inc. Business Overview 11.10.3 Zoetis, Inc. Veterinary Therapeutics Introduction 11.10.4 Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2016-2021) 11.10.5 Zoetis, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Anti-inflammatory Table 3. Key Players of Parasiticides Table 4. Key Players of Others Table 5. Global Veterinary Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Veterinary Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Veterinary Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Veterinary Therapeutics Market Share by Regions (2016-2021) Table 9. Global Veterinary Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Veterinary Therapeutics Market Share by Regions (2022-2027) Table 11. Veterinary Therapeutics Market Trends Table 12. Veterinary Therapeutics Market Drivers Table 13. Veterinary Therapeutics Market Challenges Table 14. Veterinary Therapeutics Market Restraints Table 15. Global Veterinary Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Veterinary Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Therapeutics as of 2020) Table 18. Ranking of Global Top Veterinary Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Veterinary Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Veterinary Therapeutics Product Solution and Service Table 22. Date of Enter into Veterinary Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Veterinary Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Veterinary Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Veterinary Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Veterinary Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Veterinary Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Veterinary Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Veterinary Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Veterinary Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Veterinary Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Bayer AG Company Details Table 63. Bayer AG Business Overview Table 64. Bayer AG Veterinary Therapeutics Product Table 65. Bayer AG Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 66. Bayer AG Recent Development Table 67. Boehringer Ingelheim GmbH Company Details Table 68. Boehringer Ingelheim GmbH Business Overview Table 69. Boehringer Ingelheim GmbH Veterinary Therapeutics Product Table 70. Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 71. Boehringer Ingelheim GmbH Recent Development Table 72. Ceva Sante Animale Company Details Table 73. Ceva Sante Animale Business Overview Table 74. Ceva Sante Animale Veterinary Therapeutics Product Table 75. Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 76. Ceva Sante Animale Recent Development Table 77. Dechra Pharmaceuticals PLC Company Details Table 78. Dechra Pharmaceuticals PLC Business Overview Table 79. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Table 80. Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 81. Dechra Pharmaceuticals PLC Recent Development Table 82. Eli Lilly and Company (Elanco Animal Health) Company Details Table 83. Eli Lilly and Company (Elanco Animal Health) Business Overview Table 84. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Table 85. Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 86. Eli Lilly and Company (Elanco Animal Health) Recent Development Table 87. Merck Animal Health Company Details Table 88. Merck Animal Health Business Overview Table 89. Merck Animal Health Veterinary Therapeutics Product Table 90. Merck Animal Health Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 91. Merck Animal Health Recent Development Table 92. Sanofi (Merial Animal Health) Company Details Table 93. Sanofi (Merial Animal Health) Business Overview Table 94. Sanofi (Merial Animal Health) Veterinary Therapeutics Product Table 95. Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 96. Sanofi (Merial Animal Health) Recent Development Table 97. Virbac Company Details Table 98. Virbac Business Overview Table 99. Virbac Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 100. Virbac Recent Development Table 101. Vetoquinol S.A. Company Details Table 102. Vetoquinol S.A. Business Overview Table 103. Vetoquinol S.A. Veterinary Therapeutics Product Table 104. Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 105. Vetoquinol S.A. Recent Development Table 106. Zoetis, Inc. Company Details Table 107. Zoetis, Inc. Business Overview Table 108. Zoetis, Inc. Veterinary Therapeutics Product Table 109. Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million) Table 110. Zoetis, Inc. Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Veterinary Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Anti-inflammatory Features Figure 3. Parasiticides Features Figure 4. Others Features Figure 5. Global Veterinary Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Veterinary Clinics Case Studies Figure 8. Drug Stores Case Studies Figure 9. Others Case Studies Figure 10. Veterinary Therapeutics Report Years Considered Figure 11. Global Veterinary Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Veterinary Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Veterinary Therapeutics Market Share by Regions: 2020 VS 2027 Figure 14. Global Veterinary Therapeutics Market Share by Regions (2022-2027) Figure 15. Global Veterinary Therapeutics Market Share by Players in 2020 Figure 16. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Therapeutics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2020 Figure 18. Global Veterinary Therapeutics Revenue Market Share by Type (2016-2021) Figure 19. Global Veterinary Therapeutics Revenue Market Share by Type (2022-2027) Figure 20. North America Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Veterinary Therapeutics Market Share by Type (2016-2027) Figure 22. North America Veterinary Therapeutics Market Share by Application (2016-2027) Figure 23. North America Veterinary Therapeutics Market Share by Country (2016-2027) Figure 24. United States Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Veterinary Therapeutics Market Share by Type (2016-2027) Figure 28. Europe Veterinary Therapeutics Market Share by Application (2016-2027) Figure 29. Europe Veterinary Therapeutics Market Share by Country (2016-2027) Figure 30. Germany Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Veterinary Therapeutics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Veterinary Therapeutics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Veterinary Therapeutics Market Share by Region (2016-2027) Figure 40. China Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Veterinary Therapeutics Market Share by Type (2016-2027) Figure 48. Latin America Veterinary Therapeutics Market Share by Application (2016-2027) Figure 49. Latin America Veterinary Therapeutics Market Share by Country (2016-2027) Figure 50. Mexico Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Veterinary Therapeutics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Veterinary Therapeutics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Veterinary Therapeutics Market Share by Country (2016-2027) Figure 56. Turkey Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Bayer AG Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 61. Ceva Sante Animale Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 62. Dechra Pharmaceuticals PLC Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 63. Eli Lilly and Company (Elanco Animal Health) Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 64. Merck Animal Health Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 65. Sanofi (Merial Animal Health) Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 66. Virbac Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 67. Vetoquinol S.A. Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 68. Zoetis, Inc. Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Bayer AG Boehringer Ingelheim GmbH Ceva Sante Animale Dechra Pharmaceuticals PLC Eli Lilly and Company (Elanco Animal Health) Merck Animal Health Sanofi (Merial Animal Health) Virbac Vetoquinol S.A. Zoetis, Inc.